Sientra (SIEN) Misses Q3 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Sientra Reports Third Quarter 2017 Financial Results
November 7, 2017 4:01 PM ESTCompleted FDA Facility Inspection
Completed Acquisition of Miramar Labs and Making Significant Progress with Integration
SANTA BARBARA, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (Sientra or the Company), a medical aesthetics company, today announced its financial results for the third quarter ended September 30, 2017.
Jeffrey M. Nugent, Chairman and Chief Executive Officer of Sientra, said, We continue to advance on each of our strategic initiatives, highlighted by the completion of the FDA inspection of our U.S. manufacturing facility in... More
